United States Biotechnology & Medical Research

Barinthus Biotherapeutics PLC (BRNS)

Track

Ticker: BRNS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Barinthus Biotherapeutics PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Scheeren Joseph Non-Executive Director
Transaction date
Purchase
Price
226.61
Quantity 6,091 -25.3%
Value US$3,306,075
Wright Robin Non-Executive Director
Transaction date
Purchase
Price
478.44
Quantity 22,569 +17.7%
Value US$4,845,817
0.7
Enright William Chief Executive Officer Executive Director
Transaction date
Sale
Price
118.49
Quantity 5,740 +43.8%
Value US$4,293,377
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
7.07
Quantity 25,000 -99.7%
Value US$176,708
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
5.69
Quantity 14,176 -36.1%
Value US$80,688
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
7.39
Quantity 10,000 -8.8%
Value US$73,870
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.78
Quantity 450 -85.7%
Value US$2,152
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.84
Quantity 2,175 -96.7%
Value US$10,531
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.77
Quantity 649 -89.6%
Value US$3,093
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.76
Quantity 500 -0.4%
Value US$2,381
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.82
Quantity 1,220 -1.1%
Value US$5,876
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.78
Quantity 2,200 -96.7%
Value US$10,513
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.75
Quantity 2,400 -2.0%
Value US$11,407
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
4.76
Quantity 5,350 -98.6%
Value US$25,463
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
4.50
Quantity 5,000 -4.1%
Value US$22,500
Ellis Christopher Chief Operating Officer Officer
Transaction date
Sale
Price
6.00
Quantity 5 -6.2%
Value US$30
Griffiths Graham Chief Business Officer Officer
Transaction date
Sale
Price
5.28
Quantity 8 -0.0%
Value US$42
Scheeren Joseph Non-Executive Director
Transaction date
Purchase
Price
5.09
Quantity 10,000 +333.3%
Value US$50,900
Hammacher Alex Non-Executive Director
Transaction date
Purchase
Price
5.14
Quantity 2,000 +200.0%
Value US$10,280
Hammacher Alex Non-Executive Director
Transaction date
Purchase
Price
10.86
Quantity 1,000 +inf%
Value US$10,860
Wright Robin Non-Executive Director
Transaction date
Purchase
Price
9.97
Quantity 10,000 +40.8%
Value US$99,700
Scheeren Joseph Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 3,000 +inf%
Value US$51,000
2.5
DAWES KAREN A Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 1,700 +inf%
Value US$28,900
Phillips Anne M. Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 3,000 +inf%
Value US$51,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-28 2023-06-26 B Purchase
Scheeren Joseph
Non-Executive Director
6,091 -25.3%
226.61
US$3,306,075 		6,091 -25.3% 226.61 US$3,306,075
2023-06-01 2023-05-25 B Purchase
Wright Robin
Non-Executive Director
22,569 +17.7%
478.44
US$4,845,817 		22,569 +17.7% 478.44 US$4,845,817
2023-03-29 2023-03-27 S Sale
0.7
Enright William

Chief Executive Officer

Executive Director
5,740 +43.8%
118.49
US$4,293,377 		5,740 +43.8% 118.49 US$4,293,377
2022-08-26 2022-08-25 S Sale
Ellis Christopher

Chief Operating Officer

Officer
25,000 -99.7%
7.07
US$176,708 		25,000 -99.7% 7.07 US$176,708
2022-08-26 2022-08-25 S Sale
Ellis Christopher

Chief Operating Officer

Officer
14,176 -36.1%
5.69
US$80,688 		14,176 -36.1% 5.69 US$80,688
2022-08-26 2022-08-25 S Sale
Griffiths Graham

Chief Business Officer

Officer
10,000 -8.8%
7.39
US$73,870 		10,000 -8.8% 7.39 US$73,870
2022-08-26 2022-08-24 S Sale
Ellis Christopher

Chief Operating Officer

Officer
450 -85.7%
4.78
US$2,152 		450 -85.7% 4.78 US$2,152
2022-08-19 2022-08-18 S Sale
Ellis Christopher

Chief Operating Officer

Officer
2,175 -96.7%
4.84
US$10,531 		2,175 -96.7% 4.84 US$10,531
2022-08-19 2022-08-17 S Sale
Ellis Christopher

Chief Operating Officer

Officer
649 -89.6%
4.77
US$3,093 		649 -89.6% 4.77 US$3,093
2022-08-19 2022-08-17 S Sale
Griffiths Graham

Chief Business Officer

Officer
500 -0.4%
4.76
US$2,381 		500 -0.4% 4.76 US$2,381
2022-08-17 2022-08-16 S Sale
Griffiths Graham

Chief Business Officer

Officer
1,220 -1.1%
4.82
US$5,876 		1,220 -1.1% 4.82 US$5,876
2022-08-17 2022-08-16 S Sale
Ellis Christopher

Chief Operating Officer

Officer
2,200 -96.7%
4.78
US$10,513 		2,200 -96.7% 4.78 US$10,513
2022-08-17 2022-08-15 S Sale
Griffiths Graham

Chief Business Officer

Officer
2,400 -2.0%
4.75
US$11,407 		2,400 -2.0% 4.75 US$11,407
2022-08-17 2022-08-15 S Sale
Ellis Christopher

Chief Operating Officer

Officer
5,350 -98.6%
4.76
US$25,463 		5,350 -98.6% 4.76 US$25,463
2022-08-15 2022-08-12 S Sale
Griffiths Graham

Chief Business Officer

Officer
5,000 -4.1%
4.50
US$22,500 		5,000 -4.1% 4.50 US$22,500
2022-07-15 2022-06-28 S Sale
Ellis Christopher

Chief Operating Officer

Officer
5 -6.2%
6.00
US$30 		5 -6.2% 6.00 US$30
2022-07-15 2022-06-23 S Sale
Griffiths Graham

Chief Business Officer

Officer
8 -0.0%
5.28
US$42 		8 -0.0% 5.28 US$42
2022-04-04 2022-04-01 B Purchase
Scheeren Joseph
Non-Executive Director
10,000 +333.3%
5.09
US$50,900 		10,000 +333.3% 5.09 US$50,900
2022-04-04 2022-03-31 B Purchase
Hammacher Alex
Non-Executive Director
2,000 +200.0%
5.14
US$10,280 		2,000 +200.0% 5.14 US$10,280
2022-01-04 2021-12-31 B Purchase
Hammacher Alex
Non-Executive Director
1,000 +inf%
10.86
US$10,860 		1,000 +inf% 10.86 US$10,860
2021-12-23 2021-12-22 B Purchase
Wright Robin
Non-Executive Director
10,000 +40.8%
9.97
US$99,700 		10,000 +40.8% 9.97 US$99,700
2021-05-06 2021-05-04 B Purchase
Scheeren Joseph
Non-Executive Director
3,000 +inf%
17.00
US$51,000 		3,000 +inf% 17.00 US$51,000
2021-05-06 2021-05-04 B Purchase
2.5
DAWES KAREN A
Non-Executive Director
1,700 +inf%
17.00
US$28,900 		1,700 +inf% 17.00 US$28,900
2021-05-06 2021-05-04 B Purchase
Phillips Anne M.
Non-Executive Director
3,000 +inf%
17.00
US$51,000 		3,000 +inf% 17.00 US$51,000
2021-05-06 2021-05-04 B Purchase
Oxford Sciences Innovation plc
Large shareholder
600,000 +7.3%
17.00
US$10,200,000 		600,000 +7.3% 17.00 US$10,200,000
2021-05-03 2021-04-30 B Purchase
3.6
M&G INVESTMENT MANAGEMENT LTD
Large shareholder
125,000 +13.0%
14.40
US$1,800,000 		125,000 +13.0% 14.40 US$1,800,000
Explore more

More insider trading research around Barinthus Biotherapeutics PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America